Novartis, Former Subsidiary To Pay $345M In 3 Foreign Bribery, Securities Cases

Novartis AG and a former subsidiary on June 25 agreed to pay $345 million in criminal penalties and disgorgement to resolve criminal and administrative charges that they violated the Foreign Corrupt...

Already a subscriber? Click here to view full article